By Manufacturing Process

Short-Read NGS (Illumina SBS Chemistry) Market Analysis

Cross-industry research covering Short-Read NGS (Illumina SBS Chemistry) across 1 market reportspanning Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics.

1 Reports

1 Industries

Reports Covering Short-Read NGS (Illumina SBS Chemistry)

Direct to Consumer Genetic Sequencing Market to Reach USD 4.7 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics·Market: USD 2.7 Billion (2025)·CAGR: 7.2%

Illumina's sequencing-by-synthesis chemistry powers the vast majority of targeted panel and WGS consumer products. The FY2025 revenue trajectory (edgar:ILMN-10K-2025) reflects continued dominance, but NovaSeq X price reductions are cannibalising higher-margin older platform revenues within Illumina's own mix.

40%

Market Share

9.1%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments